178 related articles for article (PubMed ID: 10946845)
1. Receptors for NPY in peripheral tissues bioassays.
Pheng LH; Regoli D
Life Sci; 2000 Jul; 67(8):847-62. PubMed ID: 10946845
[TBL] [Abstract][Full Text] [Related]
2. Peripheral modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, peptide YY, and pancreatic polypeptide in rats: cholinergic mechanisms.
Wager-Pagé SA; Raizada E; Veale W; Davison JS
Can J Physiol Pharmacol; 1993; 71(10-11):768-75. PubMed ID: 8143235
[TBL] [Abstract][Full Text] [Related]
3. Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice.
Nakajima M; Inui A; Teranishi A; Miura M; Hirosue Y; Okita M; Himori N; Baba S; Kasuga M
J Pharmacol Exp Ther; 1994 Feb; 268(2):1010-4. PubMed ID: 8113957
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y and peptide YY, but not pancreatic polypeptide, substance P, cholecystokinin and gastric inhibitory polypeptide, inhibit the glucagon- and noradrenaline-dependent increase in glucose output in rat liver.
Lüers C; Gardemann A; Miura H; Jungermann K
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):455-62. PubMed ID: 10784001
[TBL] [Abstract][Full Text] [Related]
5. Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications.
Gehlert DR
Proc Soc Exp Biol Med; 1998 May; 218(1):7-22. PubMed ID: 9572148
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis.
Holzer P; Reichmann F; Farzi A
Neuropeptides; 2012 Dec; 46(6):261-74. PubMed ID: 22979996
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus.
Acuna-Goycolea C; Tamamaki N; Yanagawa Y; Obata K; van den Pol AN
J Neurosci; 2005 Aug; 25(32):7406-19. PubMed ID: 16093392
[TBL] [Abstract][Full Text] [Related]
8. The peripheral modulation of duodenal and colonic motility in rats by the pancreatic polypeptide-fold family: neuropeptide Y, peptide YY, and pancreatic polypeptide.
Wager-Pagé SA; Ghazali B; Anderson W; Veale WL; Davison JS
Peptides; 1993; 14(2):153-60. PubMed ID: 8483795
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
Haynes JM; Hill SJ; Selbie LA
Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical distribution of neuropeptide Y, peptide YY, pancreatic polypeptide-like immunoreactivity and their receptors in the epidermal skin of healthy women.
Dumont Y; Bastianetto S; Duranton A; Breton L; Quirion R
Peptides; 2015 Aug; 70():7-16. PubMed ID: 26002416
[TBL] [Abstract][Full Text] [Related]
11. Receptors for peptide YY and neuropeptide Y on guinea pig pancreatic acini.
Huang SC; Tsai MF
Peptides; 1994; 15(3):405-10. PubMed ID: 7524045
[TBL] [Abstract][Full Text] [Related]
12. Duplication of neuropeptide Y and peptide YY in Nile tilapia Oreochromis niloticus and their roles in food intake regulation.
Yan P; Jia J; Yang G; Wang D; Sun C; Li W
Peptides; 2017 Feb; 88():97-105. PubMed ID: 27988351
[TBL] [Abstract][Full Text] [Related]
13. Spinal modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, peptide YY, and pancreatic polypeptide in rats: involvement of the cholinergic nervous system.
Wager-Pagé SA; Raizada E; Veale WL; Davison JS
Can J Physiol Pharmacol; 1993 Feb; 71(2):112-9. PubMed ID: 8319134
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa.
Cox HM; Tough IR
Br J Pharmacol; 2002 Mar; 135(6):1505-12. PubMed ID: 11906964
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of VIP-stimulated ion transport by a novel Y-receptor phenotype in rabbit distal colon.
Ballantyne GH; Goldenring JR; Fleming FX; Rush S; Flint JS; Fielding LP; Binder HJ; Modlin IM
Am J Physiol; 1993 May; 264(5 Pt 1):G848-54. PubMed ID: 8388641
[TBL] [Abstract][Full Text] [Related]
16. Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide.
Larhammar D
Regul Pept; 1996 Apr; 62(1):1-11. PubMed ID: 8738876
[TBL] [Abstract][Full Text] [Related]
17. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Widdowson PS; Buckingham R; Williams G
Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the neuropeptide Y system in the frog Silurana tropicalis (Pipidae): three peptides and six receptor subtypes.
Sundström G; Xu B; Larsson TA; Heldin J; Bergqvist CA; Fredriksson R; Conlon JM; Lundell I; Denver RJ; Larhammar D
Gen Comp Endocrinol; 2012 Jul; 177(3):322-31. PubMed ID: 22565163
[TBL] [Abstract][Full Text] [Related]
19. Different regulation of atrial ANP release through neuropeptide Y2 and Y4 receptors.
Piao FL; Yuan K; Bai GY; Han JH; Park WH; Kim SH
J Korean Med Sci; 2008 Dec; 23(6):1027-32. PubMed ID: 19119448
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y lowers blood glucose in anaesthetized rats via a Y5 receptor subtype.
Bischoff A; Michel MC
Endocrinology; 1998 Jun; 139(6):3018-21. PubMed ID: 9607814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
